Granulocyte Colony Stimulating Factor (G-CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose-Dense Chemotherapy Regimen
Introduction. Granulocyte colony-stimulating factor (G-CSF) is commonly used for prevention and treatment of febrile neutropenia among solid tumor patients. It is considered an effective and relatively safe supportive care medication; however, it can cause rare and serious side effects such as splee...
Saved in:
Main Authors: | Majed A. Alshamrani, Meteb Al-Foheidi, Ahmed H. Abdulrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/8174986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro
by: G. Bug, et al.
Published: (1998-01-01) -
Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting
by: Xu Jiang, et al.
Published: (2025-01-01) -
Using Granulocyte Colonies Stimulant Factor in the Outpatient Treatment of Post Chemotherapy Neutropenia. Interesting Aspects for a General Comprenhensive Doctor.
by: Julio Dámaso Fernández Águila, et al.
Published: (2007-04-01) -
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
by: Ahmed Alnughmush, MD, et al.
Published: (2025-02-01) -
Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration
by: Craig R. Wright, et al.
Published: (2017-01-01)